Dbfetch
ID AY069961; SV 1; linear; mRNA; STD; HUM; 885 BP. XX AC AY069961; XX DT 17-MAR-2002 (Rel. 71, Created) DT 15-OCT-2008 (Rel. 97, Last updated, Version 4) XX DE Homo sapiens lymphocyte effector toxicity activation ligand (LETAL) mRNA, DE complete cds. XX KW . XX OS Homo sapiens (human) OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. XX RN [1] RP 1-885 RX PUBMED; 14508119. RA Conejo-Garcia J.R., Benencia F., Courreges M.C., Khang E., Zhang L., RA Mohamed-Hadley A., Vinocur J.M., Buckanovich R.J., Thompson C.B., RA Levine B., Coukos G.; RT "Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation RT and expansion of effector immune cells"; RL Cancer Biol Ther 2(4):446-451(2003). XX RN [2] RP 1-885 RX DOI; 10.1158/0008-5472.CAN-03-2194. RX PUBMED; 15026360. RA Conejo-Garcia J.R., Benencia F., Courreges M.C., Gimotty P.A., Khang E., RA Buckanovich R.J., Frauwirth K.A., Zhang L., Katsaros D., Thompson C.B., RA Levine B., Coukos G.; RT "Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the RT survival and expansion of CD28- antitumor T cells"; RL Cancer Res. 64(6):2175-2182(2004). XX RN [3] RP 1-885 RA Conejo-Garcia J.-R., Zhang L., Kang E., Mohamed A., Regnani G., RA Benencia F., Courrages C., Vinacour J., Coukos G.; RT ; RL Submitted (12-DEC-2001) to the INSDC. RL Center for Research on Reproduction & Women's Health, University of RL Pennsylvania, 421 Curie Boulevard, Philadelphia, PA 19104-6142, USA XX DR MD5; 9fc1bf0949dc97e550a624a9ce0b7af5. DR Ensembl-Gn; ENSG00000164520; homo_sapiens. DR Ensembl-Tr; ENST00000357183; homo_sapiens. DR Ensembl-Tr; ENST00000367363; homo_sapiens. DR Ensembl-Tr; ENST00000529948; homo_sapiens. DR Ensembl-Tr; ENST00000532335; homo_sapiens. XX FH Key Location/Qualifiers FH FT source 1..885 FT /organism="Homo sapiens" FT /chromosome="6" FT /map="6q25" FT /mol_type="mRNA" FT /tissue_type="ovarian carcinoma" FT /db_xref="taxon:9606" FT gene 1..885 FT /gene="LETAL" FT CDS 61..852 FT /codon_start=1 FT /gene="LETAL" FT /product="lymphocyte effector toxicity activation ligand" FT /note="NKG2D-ligand" FT /db_xref="GOA:Q8TD07" FT /db_xref="H-InvDB:HIT000084156.12" FT /db_xref="HGNC:HGNC:16793" FT /db_xref="InterPro:IPR011161" FT /db_xref="InterPro:IPR011162" FT /db_xref="InterPro:IPR037055" FT /db_xref="UniProtKB/Swiss-Prot:Q8TD07" FT /protein_id="AAL58090.1" FT /translation="MRRISLTSSPVRLLLFLLLLLIALEIMVGGHSLCFNFTIKSLSRP FT GQPWCEAQVFLNKNLFLQYNSDNNMVKPLGLLGKKVYATSTWGELTQTLGEVGRDLRML FT LCDIKPQIKTSDPSTLQVEMFCQREAERCTGASWQFATNGEKSLLFDAMNMTWTVINHE FT ASKIKETWKKDRGLEKYFRKLSKGDCDHWLREFLGHWEAMPEPTVSPVNASDIHWSSSS FT LPDRWIILGAFILLVLMGIVLICVWWQNGEWQAGLWPLRTS" XX SQ Sequence 885 BP; 230 A; 204 C; 226 G; 225 T; 0 other; accataccag tgagggtgaa tgtgtacacg cccagcttcc tgcctgttac tctccacagt 60 atgcgaagaa tatccctgac ttctagccct gtgcgccttc ttttgtttct gctgttgcta 120 ctaatagcct tggagatcat ggttggtggt cactctcttt gcttcaactt cactataaaa 180 tcattgtcca gacctggaca gccctggtgt gaagcgcagg tcttcttgaa taaaaatctt 240 ttccttcagt acaacagtga caacaacatg gtcaaacctc tgggcctcct ggggaagaag 300 gtatatgcca ccagcacttg gggagaattg acccaaacgc tgggagaagt ggggcgagac 360 ctcaggatgc tcctttgtga catcaaaccc cagataaaga ccagtgatcc ttccactctg 420 caagtcgaga tgttttgtca acgtgaagca gaacggtgca ctggtgcatc ctggcagttc 480 gccaccaatg gagagaaatc cctcctcttt gacgcaatga acatgacctg gacagtaatt 540 aatcatgaag ccagtaagat caaggagaca tggaagaaag acagagggct ggaaaagtat 600 ttcaggaagc tctcaaaggg agactgcgat cactggctca gggaattctt agggcactgg 660 gaggcaatgc cagaaccgac agtgtcacca gtaaatgctt cagatatcca ctggtcttct 720 tctagtctac cagatagatg gatcatcctg ggggcattca tcctgttagt tttaatggga 780 attgttctca tctgtgtctg gtggcaaaat ggtgagtggc aggctggtct ctggcccttg 840 aggacgtctt agtctggtaa ggactcaaga gaggtgaatc atggg 885 //